163 related articles for article (PubMed ID: 28919743)
1. NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma.
Sun Y; Chen Y; Li S; Lei Y; Xu D; Jiang N; Zhang Y; Cao J; Ke Z
Int J Nanomedicine; 2017; 12():6399-6412. PubMed ID: 28919743
[TBL] [Abstract][Full Text] [Related]
2. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma.
He W; Xu D; Wang Z; Wu H; Xiang X; Tang B; Jiang W; Cui Y; Wang H; Jiang N; Sun Y; Chen Y; Li S; Hou M; Zhang Y; Wang L; Ke ZF
J Transl Med; 2019 Jan; 17(1):32. PubMed ID: 30658713
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
5. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
Murlidhar V; Reddy RM; Fouladdel S; Zhao L; Ishikawa MK; Grabauskiene S; Zhang Z; Lin J; Chang AC; Carrott P; Lynch WR; Orringer MB; Kumar-Sinha C; Palanisamy N; Beer DG; Wicha MS; Ramnath N; Azizi E; Nagrath S
Cancer Res; 2017 Sep; 77(18):5194-5206. PubMed ID: 28716896
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells in early stage lung adenocarcinoma: a case series report and literature review.
Jin XR; Zhu LY; Qian K; Feng YG; Zhou JH; Wang RW; Bai L; Deng B; Liang N; Tan QY
Oncotarget; 2017 Apr; 8(14):23130-23141. PubMed ID: 28423562
[TBL] [Abstract][Full Text] [Related]
7. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
9. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell as a diagnostic marker in primary lung cancer.
Tanaka F; Yoneda K; Kondo N; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Rahman S; Tsubota N; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
Clin Cancer Res; 2009 Nov; 15(22):6980-6. PubMed ID: 19887487
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of Axin inhibits lymphoma cell invasion and metastasis in vitro by down-regulating β-catenin and MMP7/MMP9].
Li ZJ; Ye JZ; Zhan LY; Zheng ML
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):423-8. PubMed ID: 27063176
[TBL] [Abstract][Full Text] [Related]
13. PKCζ, MMP‑2 and MMP‑9 expression in lung adenocarcinoma and association with a metastatic phenotype.
Cai X; Zhu H; Li Y
Mol Med Rep; 2017 Dec; 16(6):8301-8306. PubMed ID: 28983601
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
Zeng Q; Li S; Zhou Y; Ou W; Cai X; Zhang L; Huang W; Huang L; Wang Q
Cytokine; 2014 Jan; 65(1):24-32. PubMed ID: 24140068
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Dandachi N; Tiran V; Lindenmann J; Brcic L; Fink-Neuboeck N; Kashofer K; Absenger G; Bezan A; Cote RJ; Datar R; Balic M
Lung Cancer; 2017 Nov; 113():152-157. PubMed ID: 29110843
[TBL] [Abstract][Full Text] [Related]
20. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
Martin MD; Carter KJ; Jean-Philippe SR; Chang M; Mobashery S; Thiolloy S; Lynch CC; Matrisian LM; Fingleton B
Cancer Res; 2008 Aug; 68(15):6251-9. PubMed ID: 18676849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
